For the second year in a row, Endocrine News talks to editors from Endocrine Society journals to get the scoop on the top endocrine discoveries of 2016. The life work of a scientist requires an enormous amount of patience. “Eureka moments” take years of tireless experimentation and iteration to achieve, which is why impactful discoveries...
The Endocrine Society lauds Novo Nordisk’s recent announcement that it would limit price increases for its therapies, including insulin, and hopes that other entities in the insulin supply chain including manufacturers, pharmacy benefit managers, and insurers will also demonstrate similar restraint to address this important issue. People with type 1 diabetes are unable to produce...
With the presidential election on the horizon and NIH funding hanging in the balance, the Endocrine Society’s members have been especially active on Capitol Hill this fall. In September, the Society held a widely attended briefing on Capitol Hill about the public health impacts of endocrine-disrupting chemicals (EDCs), attended a hearing on an important piece...
Congress was able to agree to and pass a temporary funding bill before October 1 that will avert a federal government shut-down, keep the government running until December 9, and allow representatives and senators to go to their home districts and states to run for re-election. However, Congress faces a very difficult “lame duck” session...
On Wednesday September 21, the Dirksen Senate Office Building in Washington D.C., was set upon by Endocrine Society members, staff, members of congressional offices, the media, and other interested parties to learn more about endocrine-disrupting chemicals (EDCs) and the threats they pose to human health. The seminar, “From Hormones to Brain Development: 25 Years of...
The Endocrine Society has been engaged in reform of the Toxic Substances Control Act and is closely following implementation of the Frank R. Lautenberg Chemical Safety for the 21st Century Act. On August 22, the Endocrine Society submitted comments to the EPA with recommendations to address deficiencies in the existing regulatory approach. Our recommendations included...
The Society is working with the Senate on bipartisan legislation introduced by Senators Dianne Feinstein (D-CA) and Susan Collins (R-MA) known as the Personal Care Products Safety Act (S. 1014). If passed, this bill would amend the Federal Food, Drug, and Cosmetic Act to allow the FDA to collect information on the ingredients of personal care...
When Congress returns to DC on September 6, they will have less than a month to pass a funding bill to keep federal agencies operating after fiscal year 2016 ends on September 30. Because of partisan gridlock, the Congress is not expected to do that, but it can still prevent a shut-down of the federal...
Not all topics of relevance to endocrinologists are about specific conditions and diseases. Sometimes, doctors need information about changes in the medical field or the field of endocrinology. Changes to medical insurance legislation, drug trial regulations and even patient privacy legislation all impact a practitioner’s way of doing business and practicing medicine. Yet keeping track of these details is not always easy. That’s why Endocrine News has organized articles and news pieces on these topics into this advocacy page. Here, practitioners can find the information gathered by the Endocrine Society, a leading endocrinology advocacy organization, conveniently in one location.
Important Advocacy Information From the Endocrine Society
As an endocrinology advocacy organization, the Endocrine Society is constantly working to advocate for endocrinologists and their patients, both in the government and in various research centers across the country. Here on Endocrine News, you can stay informed about these efforts and their results, so you are well aware of what changes may be coming that affect your practice. This is an invaluable resource for doctors who wish to spend their time focusing on their patients, rather than advocating for their practices, but also wish to stay informed about what is happening in the field.
Both Clinical and Research Advocacy Information
On the Advocacy page, Endocrine News provides advocacy information relevant to both those in the research field and those practicing on a clinical level. Stay up to date with the activities of the Endocrine Society, learn more about the legislation that affects your work, and see highlights of leading researchers who are pioneering not only advances in the practice but also advocacy for endocrinology as a field. By utilizing the resources on the Advocacy page, you will be better equipped to meet the needs of your patients while staying abreast on the changes affecting the industry.
For the second year in a row, Endocrine News talks to editors from Endocrine Society journals to get the scoop on the top endocrine discoveries of 2016. The life work of a scientist requires an enormous amount of patience. “Eureka moments” take years of tireless experimentation and iteration to achieve, which is why impactful discoveries...
